Tomáš Štulc
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Family Practice top 10%
Papers in
- Surgery 24
- Lipoproteins and Cardiovascular Health 22
-
- Cardiovascular Health and Disease Prevention 8
- Blood Pressure and Hypertension Studies 3
- Co-authors
- R Češka (42 shared papers)Peter P. Tóth (1 shared paper)Ricardo Dent (1 shared paper)Maciej Banach (1 shared paper)Michal Vrablı́k (24 shared papers)Aleksi Šedo (1 shared paper)Jan Malík (9 shared papers)Antonio M. Gotto (2 shared papers)
- Journals
- Physiological Research (13 papers)Atherosclerosis Supplements (5 papers)Current Atherosclerosis Reports (4 papers)American Heart Journal (2 papers)Nutrition (1 paper)
- Partner nations
- CzechiaUnited StatesSwitzerland
In The Last Decade
Tomáš Štulc
56 papers receiving 968 citations
Peers
Comparison fields: 5 of 76
- Endocrinology, Diabetes and Metabolism 195
- Family Practice 20
- Surgery 476
- Cancer Research 97
- Cardiology and Cardiovascular Medicine 138
Countries citing papers authored by Tomáš Štulc
This map shows the geographic impact of Tomáš Štulc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Štulc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Štulc more than expected).
Fields of papers citing papers by Tomáš Štulc
This network shows the impact of papers produced by Tomáš Štulc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Štulc. The network helps show where Tomáš Štulc may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomáš Štulc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 265 | |
| 2 | 2016 | 148 | |
| 3 | 2014 | 47 | |
| 4 | 2010 | 45 | |
| 5 | 2015 | 42 | |
| 6 | 2004 | 30 | |
| 7 | 2003 | 29 | |
| 8 | 2007 | 28 | |
| 9 | 2004 | 27 | |
| 10 | 2001 | 27 | |
| 11 | Microvascular reactivity in patients with hypercholesterolemia: effect of lipid lowering treatment. | 2003 | 26 |
| 12 | 2003 | 23 | |
| 13 | 2007 | 21 | |
| 14 | 2003 | 20 | |
| 15 | 2000 | 18 | |
| 16 | 2008 | 17 | |
| 17 | 2009 | 13 | |
| 18 | Statin intolerance: the clinician’s perspective | 2016 | 12 |
| 19 | 2006 | 11 | |
| 20 | 2008 | 11 |
About Tomáš Štulc
Tomáš Štulc is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Cancer Research and Molecular Biology, having authored 58 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (22 papers), Cardiovascular Health and Disease Prevention (8 papers), Cancer, Lipids, and Metabolism (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Blood Pressure and Hypertension Studies (3 papers) and Pharmaceutical Economics and Policy (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (195 citations), Family Practice (20 citations), Surgery (476 citations), Cancer Research (97 citations) and Cardiology and Cardiovascular Medicine (138 citations). Tomáš Štulc has collaborated with scholars based in Czechia, United States and Switzerland. Frequent co-authors include R Češka, Peter P. Tóth, Ricardo Dent, Maciej Banach, Michal Vrablı́k, Aleksi Šedo, Jan Malík, Antonio M. Gotto, J Škrha and Marjel van Dam. Their work appears in journals such as Physiological Research, Atherosclerosis Supplements, Current Atherosclerosis Reports, American Heart Journal and Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.